TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results April 4, 1986